Log in to save to my catalogue

Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy

Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6797810

Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy

About this item

Full title

Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2019-10, Vol.10 (11), p.786-16, Article 786

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

MYCN
-amplified (MNA) neuroblastoma is an aggressive neural crest-derived pediatric cancer. However, MYCN is indispensable for development and transcriptionally regulates extensive network of genes. Integrating anti-MYCN ChIP-seq and gene expression profiles of neuroblastoma patients revealed the metabolic enzymes,
MTHFD2
and
PAICS
,...

Alternative Titles

Full title

Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6797810

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6797810

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-019-2033-z

How to access this item